AOD-9604
An analogue of amino acids 177-191 of the C-terminus of human growth hormone, with an additional Tyr residue at the N-terminus. AOD-9604 has been studied for its selective lipolytic and anti-lipogenic properties without measurable effects on IGF-1 or blood glucose — distinguishing it as a metabolic research compound.
Research Use Only. AOD-9604 is sold exclusively for in vitro research and laboratory use by qualified scientists. Not for human consumption, veterinary use, or clinical administration.
Research Literature
Published Research
AOD-9604 selectively targets adipose tissue lipolysis without affecting glucose metabolism or IGF-1, offering a clean metabolic research model.
Metabolic effects of AOD-9604 in obesity models
Key finding: AOD-9604 reduces fat mass through selective lipolysis stimulation without diabetogenic or growth-promoting effects.
PubMed 10417774 ↗AOD-9604 dose-response in adipose tissue research
Key finding: Dose-dependent fat reduction with no measurable impact on IGF-1 levels or glucose tolerance.
PubMed 12126431 ↗Safety profile of HGH fragment AOD-9604
Key finding: Human safety studies demonstrated tolerability with no bone, cartilage or insulin pathway interference.
PubMed 15272051 ↗Same Category